CXCL12 and breast cancer: Radiation-induced modifications in SDF-1/CXCR4 signaling, in turn, have been reported in gliomas (116, 125, 127, 137), mesotheliomas (138), prostate (139), cervical (140), lung (131, 141) and breast cancer (131).